Arix Bioscience Overview

  • Investor Type
  • Venture Capital
  • Status
  • Active
  • Professionals
  • 9
Professionals
  • Investments
  • 29
  • Portfolio
  • 16
  • Exits
  • 10
Exits

Arix Bioscience General Information

Description

Founded in 2016, Arix Bioscience is a listed venture capital firm based in London, United Kingdom. The firm invests in seed-stage companies, preclinical and clinical-stage assets, private or public companies across biotech, healthcare and life science sectors.

Contact Information

Year Founded
2016
Investor Status
Actively Seeking New Investments
Primary Investor Type
Venture Capital
Other Investor Types
Growth/Expansion
Primary Office
  • 20 Berkeley Square
  • London W1J 6EQ
  • England, United Kingdom
+44 020 0000 0000

Arix Bioscience Investments & Acquisitions (29)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
VelosBio 02-Jul-2020 Early Stage VC 00000 Drug Discovery Clinical Trials - Phase 2 00000000 00000 00.0
00000000 08-May-2020 00000 00000 0000 Drug Discovery Clinical Trials - Phase 2 000000 00000000 00.0
00000 01-Feb-2020 00000 00000 000.00 Biotechnology Clinical Trials - Phase 2 0000 0000
000000 000 27-Jan-2020 00000 00000 000.00 Biotechnology Startup 00000000 00000 00.0
000000 09-Jan-2020 00000 00000 000.00 Pharmaceuticals Generating Revenue 000000 00000000 00.0
00000 000000000000 30-Sep-2019 00000 00000 0000 Drug Discovery Generating Revenue 00000000 00000 00.0
0000 000 30-Apr-2019 00000 00000 0000 Biotechnology Generating Revenue 00000000 00000 00.0
0000 00000000000 02-Apr-2019 00000 00000 0000 Biotechnology Generating Revenue 0000 0000
Harpoon Therapeutics 08-Feb-2019 IPO 0000 Biotechnology Generating Revenue/Not Profitable 0000 0000
Aura Biosciences 13-Dec-2018 Later Stage VC 000.00 Biotechnology Generating Revenue 0000 0000
You’re viewing 10 of 29 investments and acquisitions. Get the full list »
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Arix Bioscience Exits (10)

Company Name Exit Date Exit Type Exit Size
VelosBio 18-Dec-2020 Merger/Acquisition 00.000
000000 00000000000 26-Oct-2020 000000 0000000000 000.00
00000 12-Mar-2020 000 000.00
0000000 22-Jan-2020 000000000 00000000
0000000 11-Apr-2019 000000 0000000000 00000
0000000 0000000000 08-Feb-2019 000 0000
00000000 000000000 19-Oct-2018 000 0000
0000000 22-Jun-2018 000 00000
Iterum Therapeutics 25-May-2018 IPO 0000
Verona Pharma 26-Apr-2017 Public Investment 2nd Offering 0000
To view Arix Bioscience’s complete exits history, request access »

Arix Bioscience Investments by Industry, Year, and Region

Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.

Request a free trial

Arix Bioscience Team (21)

Name Title Deals Funds Boards Office
Robert Lyne Chief Operating Officer & General Counsel London, United Kingdom
Christian Schetter Ph.D Managing Director 0 London, United Kingdom
Jonathan Tobin Ph.D Managing Director 0 0 0 London, United Kingdom
John Cassidy Ph.D Principal 0 London, United Kingdom
Michelle Keating Financial Controller London, United Kingdom
You’re viewing 5 of 21 team members. Get the full list »

Arix Bioscience Co-Investors (83)

Name With Exits Lead Partner Series Industry
OrbiMed 6 0 0 Series chart Industry bar
Lundbeckfond Ventures 0 0 Series chart Industry bar
Cormorant Asset Management 0 0 0 Series chart Industry bar
Sofinnova Investments 0 0 0 Series chart Industry bar
Pappas Capital 0 0 0 Series chart Industry bar
You’re viewing 5 of 83 co-investors. Get the full list »